
Case Report
The Cureus Journal of Medical Science is proud to introduce the Negative Pressure Wound Therapy with Instillation and Dwell: Clinical Results in Cleansing and Removal of Infectious Material with Novel Dressings publishing competition.
Negative pressure wound therapy with instillation and dwell (NPWTi-d) combines the benefits of NPWT with controlled delivery of topical solutions and suspensions over the wound bed reducing edema and promoting perfusion and granulation tissue formation. When used with novel dressings such as reticulated open-celled foam with through holes (ROCF-CC), the combination facilitates the removal of thick exudate and infectious material, such as fibrin and slough, providing a wound cleansing option for clinicians when surgical debridement must be delayed or is not possible or appropriate.
To encourage continued research and knowledge sharing focused on recent advances to Negative Pressure Wound Therapy with Instillation, we are seeking the following:
To foster educational awareness, our goal is to share the results with the broad surgical community worldwide. To encourage dissemination, all published materials will be Open Access and indexed with PubMed Central. We encourage any clinicians in the wound therapy field to contribute!
Program administration has been enabled through the financial support of KCI, an Acelity company. Article selection, editorial review, peer review, publication and competition winner determination are strictly independent of the sponsor.
All article submissions will undergo an independent pre-publication peer review conducted by a world-class team of experts.
The entry period is now closed. Competition entries appear below as they are published. Now is your chance to score and discuss these articles. Remember, prizes will be awarded to the three highest-scoring articles!
Competition entry and article submission is entirely free. All submitted work must be previously unpublished. Eligible entries include original articles, case reports and technical reports.
All articles must be submitted and formatted via the template-driven, self-publishing Cureus platform. Authors are encouraged to include supporting animations and videos within their article submissions. Reference limits vary by article type. For additional information on publishing with Cureus, please refer to our Author Guide.
Other Stipulations
Winning Article Awards
Three Cureus Scientific Excellence™ prizes will be awarded to the published articles that receive the highest Cureus SIQ™ (Scholarly Impact Quotient™) score:
Subsequent to a formal editorial and peer review, published articles undergo SIQ scoring - Cureus’ unique crowdsourced, secondary peer-review process. In addition to measuring engagement, SIQ allows the community-at-large to rate the quality of individual articles. Reviewers assign scores from 1 to 10 on criteria including clarity and rationale, clinical importance, study design and methods, data analysis, novelty of conclusions and quality of presentation.
Aggregated community SIQ scores allow clinicians and researchers to quickly assess article quality in a manner similar to that of Amazon® and Yelp® community reviews.
Eligible articles must receive a minimum of 5 scores. (A Cureus user can assign only one score per article.) As engagement and scoring is critical to winning, authors are highly encouraged to share their published articles via social media and email.
Sunshine Act Reporting
Section 6002 of the Affordable Care Act requires applicable manufacturers of covered drugs, devices, biologicals, and medical supplies to report payments or other transfers of value made to physicians and teaching hospitals. For winning article and referral awards paid to “covered recipients,” award fees shall be supplied to KCI for subsequent Sunshine Act reporting.